{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001709941","name":"BioAge Labs, Inc.","summary":"BioAge Labs is a clinical-stage biopharmaceutical company developing therapeutics for metabolic diseases by targeting human aging biology. Its lead program, BGE-102, is an orally available, brain-penetrant NLRP3 inhibitor in Phase 1 trials for cardiometabolic disease and diabetic macular edema. The company also develops APJ agonists for obesity and has collaborations with Eli Lilly and Novartis for platform-derived target discovery.","people":[],"products":[{"name":"BGE-102","type":"platform","description":"Potent, structurally novel, orally available, brain-penetrant small-molecule NLRP3 inhibitor in Phase 1 for cardiometabolic disease and diabetic macular edema."},{"name":"APJ Agonist Programs (oral and parenteral)","type":"platform","description":"Novel apelin receptor APJ agonists for obesity treatment, targeting both oral and subcutaneous administration; IND filing planned by 2026 year end."},{"name":"BioAge Human Aging Platform","type":"platform","description":"Proprietary longitudinal human datasets with over 150 million molecular data points and 25,000+ participant profiles spanning 50+ years used for target identification."}],"partnerships":[{"partner_name":"Eli Lilly and Company","partnership_type":"development","description":"Ongoing collaboration advancing earlier-stage platform-derived programs in cardiometabolic disease through molecule discovery stage.","start_date":null},{"partner_name":"Novartis Pharma AG","partnership_type":"development","description":"Ongoing target discovery collaboration to identify and expand pipeline candidates.","start_date":null},{"partner_name":"JiKang Therapeutics","partnership_type":"licensing","description":"Option agreement announced June 2025 for a novel APJ agonist antibody for obesity treatment.","start_date":null}],"affiliations":[],"origin":{"leaf":"8f7095f994b33fdb62b30ea616d9a7c0f8a3098963a98a3337b3b2f91be4d646","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"b3b799ab8cebacf2cc79c96a5d03c8c85eed16d880e8472bae9f1a338a320eb5","parent":"6a615e83f9ffbd71139422b3d61f6db1fed065b5dd4c1b3293c2cd9509490a8e","source":"0001193125-26-120873","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":164,"hourly_limit":500,"remaining":336,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}